Fred Lucas is chief news correspondent and manager of the Investigative Reporting Project for The Daily Signal. He is the author of “The Myth of Voter Suppression: The Left’s Assault on Clean Elections.” Send an email to Fred.
The institutional Left is dumping millions into what has become the most expensive redistricting ballot initiative in history—to change how a red-leaning state elects members of Congress and the state Legislature.
The Sixteen Thirty Fund, a client of Arabella Advisors, is the largest donor to the Ohio ballot question, dubbed Issue 1.
If voters approve it, Issue 1 would amend the state’s Constitution to establish what proponents call a nonpartisan Citizen Redistricting Commission, according to Ballotpedia.
Supporters of the change have given a total of $26.1 million, according to campaign finance data from July, the most recently available from the Ohio Secretary of State’s Office. The total includes multimillion-dollar contributions from the liberal Tides Foundation and the American Civil Liberties Union. […]
— Read More: www.dailysignal.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
